Home › Companies › PDS BIOTECHNOLOGY CORP. › 2023-2024
Compiled from SEC Form N-PX filings and PDS BIOTECHNOLOGY CORP.’s Form 8-K, filed 2024-06-24 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Proxy season: 2023-2024
Explore PDS BIOTECHNOLOGY CORP. in the interactive database Compare manager voting policies
These tallies are PDS BIOTECHNOLOGY CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Frank Bedu-Addo, Ph.D. | 6,718,008 | -- | -- | 1,506,996 | 12,556,503 | Majority: yes |
| Elect Director: Otis Brawley, M.D. | 6,417,459 | -- | -- | 1,807,545 | 12,556,503 | Majority: yes |
| Proposal 2: A proposal to approve an amendment to the Eighth Amended and Restated Certificate of Incorporation | 15,482,514 | 4,285,087 | 1,013,906 | -- | 0 | Majority: yes |
| Proposal 3: A proposal to ratify the appointment of KPMG US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 20,368,680 | 302,894 | 109,933 | -- | 0 | Majority: yes |
| Proposal 4: A proposal to approve, by non-binding advisory vote, the compensation of the Company's named executive officers | 5,739,901 | 1,825,608 | 659,495 | -- | 12,556,503 | Majority: yes |
Source: PDS BIOTECHNOLOGY CORP., Form 8-K, filed with the SEC on 2024-06-24 — read the filing on EDGAR.
Each item below shows how the 107 asset managers that disclosed a PDS BIOTECHNOLOGY CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PDS BIOTECHNOLOGY CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2024-06-24.
Combines 5 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
PDS BIOTECHNOLOGY CORP.’s own tally for this item (“Proposal 4: A proposal to approve, by non-binding advisory vote, the compensation of the Company's named executive officers”): 5,739,901 for, 1,825,608 against, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 36,679,275 outstanding shares: 16% for, 5% against (21% of the company cast a for/against vote).
The 88 asset managers below cast 88% of the shares they voted on this item FOR (1,596,990 for, 218,953 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 329,105 | 0 | 0 | 0 | For |
| State Street | 312,347 | 0 | 0 | 0 | For |
| Vanguard | 283,351 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 142,635 | 0 | 0 | 0 | For |
| Northern Trust | 124,519 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 100,008 | 0 | 0 | Against |
| Global X | 0 | 51,576 | 0 | 0 | Against |
| Equitable | 42,968 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 42,137 | 0 | 0 | 0 | For |
| AllianceBernstein | 37,840 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 26,567 | 0 | 0 | 0 | For |
| Citadel | 25,408 | 0 | 0 | 0 | For |
| Lincoln Financial | 23,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,270 | 0 | 0 | 0 | For |
| Invesco | 0 | 19,083 | 0 | 0 | Against |
| John Hancock | 13,396 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,587 | 0 | 0 | 0 | For |
| Rhumbline | 10,998 | 0 | 0 | 0 | For |
| JPMorgan | 10,963 | 0 | 0 | 0 | For |
| Fidelity | 10,286 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 9,812 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 9,724 | 0 | 0 | 0 | For |
| Goldman Sachs | 9,429 | 0 | 0 | 0 | For |
| Dimensional | 0 | 9,284 | 0 | 0 | Against |
| Pacific Life | 8,633 | 0 | 0 | 0 | For |
Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.
Meeting held 2023-07-14; no official results are on file for this meeting.
Combines 3 wordings of this item as funds reported it.
99.7% fund support · no official result
The 41 asset managers below cast 99.7% of the shares they voted on this item FOR (3,248,434 for, 9,478 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 637,475 | 0 | 0 | 0 | For |
| Two Sigma | 501,098 | 0 | 0 | 0 | For |
| BlackRock | 432,980 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 285,270 | 0 | 0 | 0 | For |
| FIRST MANHATTAN CO. LLC. | 271,576 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 253,853 | 0 | 0 | 0 | For |
| Fidelity | 236,807 | 0 | 0 | 0 | For |
| Renaissance | 103,405 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 100,000 | 0 | 0 | 0 | For |
| Point72 | 86,082 | 0 | 0 | 0 | For |
| Citadel | 84,149 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 61,106 | 0 | 0 | 0 | For |
| State Street | 42,610 | 0 | 0 | 0 | For |
| Charles Schwab | 26,556 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 18,910 | 0 | 0 | 0 | For |
| Dimensional | 18,622 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 15,730 | 0 | 0 | 0 | For |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,900 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 8,532 | 0 | 0 | 0 | For |
| Invesco | 0 | 7,728 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 7,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,734 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 6,413 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 5,438 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Meeting held 2024-06-24.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
PDS BIOTECHNOLOGY CORP.’s own tally for this item (“Proposal 3: A proposal to ratify the appointment of KPMG US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 20,368,680 for, 302,894 against, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 36,679,275 outstanding shares: 56% for, 0.9% against (56% of the company cast a for/against vote).
The 35 asset managers below cast 99.2% of the shares they voted on this item FOR (668,266 for, 5,000 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 270,283 | 0 | 0 | 0 | For |
| BlackRock | 190,052 | 0 | 0 | 0 | For |
| Global X | 51,576 | 0 | 0 | 0 | For |
| Equitable | 42,968 | 0 | 0 | 0 | For |
| Lincoln Financial | 23,500 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,587 | 0 | 0 | 0 | For |
| Northern Trust | 10,721 | 0 | 0 | 0 | For |
| Pacific Life | 8,633 | 0 | 0 | 0 | For |
| Fidelity | 8,523 | 0 | 0 | 0 | For |
| John Hancock | 6,662 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,344 | 0 | 0 | 0 | For |
| Greenwich Investment Management, Inc. | 0 | 5,000 | 0 | 0 | Against |
| Bridge Builder Trust | 4,848 | 0 | 0 | 0 | For |
| TIAA | 4,831 | 0 | 0 | 0 | For |
| Charles Schwab | 3,903 | 0 | 0 | 0 | For |
| Invesco | 3,863 | 0 | 0 | 0 | For |
| Voya | 3,605 | 0 | 0 | 0 | For |
| Principal | 3,271 | 0 | 0 | 0 | For |
| Calvert | 2,309 | 0 | 0 | 0 | For |
| State Street | 2,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,731 | 0 | 0 | 0 | For |
| ProShares | 1,571 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,100 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| Dimensional | 1,055 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held 2024-06-24.
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
PDS BIOTECHNOLOGY CORP.’s own tally for this item (“Elect Director: Frank Bedu-Addo, Ph.D.”): 6,718,008 for, 1,506,996 withheld, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 36,679,275 outstanding shares: 18% for, 4% withheld (22% of the company cast a for/withheld vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (631,211 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 270,283 | 0 | 0 | 0 | For |
| BlackRock | 190,052 | 0 | 0 | 0 | For |
| Global X | 51,576 | 0 | 0 | 0 | For |
| Equitable | 42,968 | 0 | 0 | 0 | For |
| Lincoln Financial | 23,500 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 11,587 | 0 | Abstain |
| Northern Trust | 10,721 | 0 | 0 | 0 | For |
| Pacific Life | 8,633 | 0 | 0 | 0 | For |
| Fidelity | 8,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,662 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 5,344 | 0 | Abstain |
| Bridge Builder Trust | 4,848 | 0 | 0 | 0 | For |
| TIAA | 4,831 | 0 | 0 | 0 | For |
| Charles Schwab | 3,903 | 0 | 0 | 0 | For |
| Invesco | 3,863 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 3,605 | 0 | Abstain |
| Principal | 0 | 0 | 3,271 | 0 | Abstain |
| Calvert | 0 | 0 | 2,309 | 0 | Abstain |
| State Street | 2,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,731 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 1,571 | 0 | Abstain |
| Blackstone Alternative Investment Funds | 0 | 0 | 1,100 | 0 | Abstain |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 1,055 | 0 | Abstain |
| Morgan Stanley | 1,007 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Meeting held 2024-06-24.
Combines 3 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
PDS BIOTECHNOLOGY CORP.’s own tally for this item (“Elect Director: Otis Brawley, M.D.”): 6,417,459 for, 1,807,545 withheld, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 36,679,275 outstanding shares: 17% for, 5% withheld (22% of the company cast a for/withheld vote).
The 34 asset managers below cast 100% of the shares they voted on this item FOR (554,203 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 270,283 | 0 | 0 | 0 | For |
| BlackRock | 190,052 | 0 | 0 | 0 | For |
| Global X | 51,576 | 0 | 0 | 0 | For |
| Equitable | 5,128 | 0 | 37,840 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 23,500 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 11,587 | 0 | Abstain |
| Northern Trust | 0 | 0 | 10,721 | 0 | Abstain |
| Pacific Life | 8,633 | 0 | 0 | 0 | For |
| Fidelity | 8,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,662 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 5,344 | 0 | Abstain |
| Bridge Builder Trust | 4,848 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 4,831 | 0 | Abstain |
| Charles Schwab | 3,903 | 0 | 0 | 0 | For |
| Invesco | 3,863 | 0 | 0 | 0 | For |
| Voya | 3,605 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 3,271 | 0 | Abstain |
| Calvert | 0 | 0 | 2,309 | 0 | Abstain |
| State Street | 0 | 0 | 2,000 | 0 | Abstain |
| T. Rowe Price | 1,731 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 1,571 | 0 | Abstain |
| Blackstone Alternative Investment Funds | 0 | 0 | 1,100 | 0 | Abstain |
| PENN SERIES FUNDS INC | 0 | 0 | 1,100 | 0 | Abstain |
| Dimensional | 0 | 0 | 1,055 | 0 | Abstain |
| Morgan Stanley | 1,007 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Meeting held 2024-06-24.
Combines 3 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
PDS BIOTECHNOLOGY CORP.’s own tally for this item (“Proposal 2: A proposal to approve an amendment to the Eighth Amended and Restated Certificate of Incorporation”): 15,482,514 for, 4,285,087 against, per its Form 8-K filed 2024-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 36,679,275 outstanding shares: 42% for, 12% against (53.9% of the company cast a for/against vote).
The 34 asset managers below cast 92% of the shares they voted on this item FOR (611,827 for, 56,439 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 270,283 | 0 | 0 | 0 | For |
| BlackRock | 190,052 | 0 | 0 | 0 | For |
| Global X | 0 | 51,576 | 0 | 0 | Against |
| Equitable | 42,968 | 0 | 0 | 0 | For |
| Lincoln Financial | 23,500 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,587 | 0 | 0 | 0 | For |
| Northern Trust | 10,721 | 0 | 0 | 0 | For |
| Pacific Life | 8,633 | 0 | 0 | 0 | For |
| Fidelity | 8,523 | 0 | 0 | 0 | For |
| John Hancock | 6,662 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,344 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,848 | 0 | 0 | 0 | For |
| TIAA | 4,831 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 3,903 | 0 | 0 | Against |
| Invesco | 3,863 | 0 | 0 | 0 | For |
| Voya | 3,605 | 0 | 0 | 0 | For |
| Principal | 3,271 | 0 | 0 | 0 | For |
| Calvert | 2,309 | 0 | 0 | 0 | For |
| State Street | 2,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,731 | 0 | 0 | 0 | For |
| ProShares | 1,571 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 1,100 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| Dimensional | 1,055 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,007 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Meeting held 2023-07-14; no official results are on file for this meeting.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 13 asset managers below cast 100% of the shares they voted on this item FOR (971,253 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 624,929 | 0 | 0 | 0 | For |
| Fidelity | 236,756 | 0 | 0 | 0 | For |
| BlackRock | 58,168 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 18,910 | 0 | 0 | 0 | For |
| Charles Schwab | 13,278 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 8,993 | 0 | Abstain |
| Blackstone Alternative Investment Funds | 7,400 | 0 | 0 | 0 | For |
| Equitable | 4,391 | 0 | 0 | 0 | For |
| Invesco | 3,864 | 0 | 0 | 0 | For |
| Victory Capital | 1,737 | 0 | 0 | 0 | For |
| American Century | 1,102 | 0 | 0 | 0 | For |
| John Hancock | 567 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 151 | 0 | 0 | 0 | For |
Meeting held 2023-07-14; no official results are on file for this meeting.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 13 asset managers below cast 100% of the shares they voted on this item FOR (700,917 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 624,929 | 0 | 0 | 0 | For |
| Fidelity | 0 | 0 | 236,756 | 0 | Abstain |
| BlackRock | 58,168 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 0 | 18,910 | 0 | Abstain |
| Charles Schwab | 13,278 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 8,993 | 0 | Abstain |
| Blackstone Alternative Investment Funds | 0 | 0 | 7,400 | 0 | Abstain |
| Equitable | 4,391 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 3,864 | 0 | Abstain |
| Victory Capital | 0 | 0 | 1,737 | 0 | Abstain |
| American Century | 0 | 0 | 1,102 | 0 | Abstain |
| John Hancock | 0 | 0 | 567 | 0 | Abstain |
| WILSHIRE MUTUAL FUNDS INC | 151 | 0 | 0 | 0 | For |
Meeting held 2023-07-14; no official results are on file for this meeting.
Combines 3 wordings of this item as funds reported it.
100% fund support · no official result
The 13 asset managers below cast 100% of the shares they voted on this item FOR (980,246 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 624,929 | 0 | 0 | 0 | For |
| Fidelity | 236,756 | 0 | 0 | 0 | For |
| BlackRock | 58,168 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 18,910 | 0 | 0 | 0 | For |
| Charles Schwab | 13,278 | 0 | 0 | 0 | For |
| Dimensional | 8,993 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 7,400 | 0 | 0 | 0 | For |
| Equitable | 4,391 | 0 | 0 | 0 | For |
| Invesco | 3,864 | 0 | 0 | 0 | For |
| Victory Capital | 1,737 | 0 | 0 | 0 | For |
| American Century | 1,102 | 0 | 0 | 0 | For |
| John Hancock | 567 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 151 | 0 | 0 | 0 | For |
Meeting held 2023-07-14; no official results are on file for this meeting.
Combines 2 wordings of this item as funds reported it.
75% fund support · no official result
The 11 asset managers below cast 75% of the shares they voted on this item FOR (737,806 for, 241,722 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 624,929 | 0 | 0 | 0 | For |
| Fidelity | 0 | 236,756 | 0 | 0 | Against |
| BlackRock | 58,168 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 18,910 | 0 | 0 | 0 | For |
| Charles Schwab | 13,278 | 0 | 0 | 0 | For |
| Dimensional | 8,993 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 7,400 | 0 | 0 | 0 | For |
| Equitable | 4,391 | 0 | 0 | 0 | For |
| Invesco | 0 | 3,864 | 0 | 0 | Against |
| Victory Capital | 1,737 | 0 | 0 | 0 | For |
| American Century | 0 | 1,102 | 0 | 0 | Against |
Meeting held 2023-07-14; no official results are on file for this meeting.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (718 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| John Hancock | 567 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 151 | 0 | 0 | 0 | For |
Ranked by the number of PDS BIOTECHNOLOGY CORP. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 36,679,275 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 0.90% |
| 2 | State Street | 0.85% |
| 3 | Vanguard | 0.77% |
| 4 | Sofinnova Investments, Inc. | 0.39% |
| 5 | Northern Trust | 0.34% |
| 6 | PNC BANK, NATIONAL ASSOCIATION | 0.27% |
| 7 | Global X | 0.14% |
| 8 | Equitable | 0.12% |
| 9 | MELLON INVESTMENTS Corp | 0.11% |
| 10 | AllianceBernstein | 0.10% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 5.18% | 13F |
| Geode Capital | 1.78% | 13F |
| State Street | 1.52% | 13F |
| BlackRock | 1.41% | 13F |
| Renaissance Technologies | 0.97% | 13F |
| Northern Trust | 0.66% | 13F |
| Citadel Advisors | 0.36% | 13F |
| Nuveen | 0.30% | 13F |
| BNY Mellon | 0.27% | 13F |
| Charles Schwab | 0.21% | 13F |
Percentages above are of 36,679,275 shares outstanding, as reported by PDS BIOTECHNOLOGY CORP. on its Form 10-Q dated 2024-05-08 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PDS BIOTECHNOLOGY CORP.’s 10-Q dated 2024-05-08. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At PDS BIOTECHNOLOGY CORP.'s 2 shareholder meetings in the 2023-2024 proxy season (held 2023-07-14 and 2024-06-24), 107 asset managers reported how they voted in their SEC Form N-PX filings, covering 713 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2024-06-24 — To approve, by non-binding, advisory vote, the compensation of our named executive officers. — FOR was 76% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PDS BIOTECHNOLOGY CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-24.
PDS BIOTECHNOLOGY CORP. proxy season coverage: 2023-2024 (this page).